The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.
The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining this market's growth.
Based on product, the consumables segment holds the largest market share during the forecast period
Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. The dominant share and high growth of the consumables segment can be attributed to the repeated purchase of consumables and increased funding for cell-based research.
Based on application, the biopharmaceutical production segment is expected to register the highest CAGR during the forecast period
Based on application, the cell culture market is categorized into biopharmaceutical production, stem cell research, diagnostics, drug screening & development, tissue engineering and regenerative medicine, and other applications. The biopharmaceutical production application segment is expected to register the highest CAGR during the forecast period.The high growth of this segment is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and the increasing demand for monoclonal antibodies (mAbs).
Pharmaceutical & Biotechnology companies end-user segment is expected to grow at the highest CAGR in the cell culture market during the forecast period
Based on end-users, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals and diagnostic centers, and cell banks. The pharmaceutical & biotechnology companies segment is expected to witness the highest growth during the forecast period. The growing use of single-use technologies, the increasing number of regulatory approvals for cell culture-based vaccines, and the presence of a large number of pharmaceutical players in this market are some of the factors driving the cell culture market for this end-user segment.
North America is expected to account for the largest share of the cell culture market in 2019
In 2019, North America accounted for the largest share of the cell culture market, followed by Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the growing regulatory approvals for cell culture-based vaccines, technological advancements, and growth in the biotechnology & pharmaceutical industries in the region are the key factors driving the growth of the cell culture market in North America.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights 4.1 Cell Culture: Market Overview 4.2 Asia-Pacific: Cell Culture Market Share, by End-user and Country (2019) 4.3 Cell Culture Market: Geographic Growth Opportunities 4.4 Regional Mix: Cell Culture Market 4.5 Cell Culture Market: Developed Vs. Developing Markets
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Market Drivers 220.127.116.11 Growing Awareness About the Benefits of Cell Culture-Based Vaccines 18.104.22.168 Increasing Demand for Monoclonal Antibodies 22.214.171.124 Funding for Cell-Based Research 126.96.36.199 Growing Preference for Single-Use Technologies 188.8.131.52 Launch of Advanced Cell Culture Products 184.108.40.206 Growing Focus on Personalized Medicine 5.2.2 Market Restraints 220.127.116.11 High Cost of Cell Biology Research 18.104.22.168 Lack of Infrastructure for Cell-Based Research in Emerging Economies 5.2.3 Market Opportunities 22.214.171.124 Growing Demand for 3D Cell Culture 126.96.36.199 The Growing Risk of Pandemics and Communicable Diseases 188.8.131.52 Emerging Economies 5.3 COVID-19 Impact on the Cell Culture Market 5.4 Value Chain Analysis 5.5 Supply Chain Analysis 5.6 Ecosystem Analysis 5.7 Regulatory Analysis
6 Cell Culture Market, by Product 6.1 Introduction 6.2 Impact of the COVID-19 on the Cell Culture Market 6.3 Consumables 6.3.1 Sera, Media, and Reagents 184.108.40.206 Media 220.127.116.11.1 Serum-Free Media 18.104.22.168.1.1 Lack of Sera Eliminates the Risk of Contamination by Viruses 22.214.171.124.2 Classical Media & Salts 126.96.36.199.2.1 Classical Media is Commonly Used in Virology, Vaccine Production, and Primary Tissue Explant Culture 188.8.131.52.3 Stem Cell Culture Media 184.108.40.206.3.1 Stem Cell Culture Media to Witness the Highest Growth in the APAC Market During the Forecast Period 220.127.116.11.4 Specialty Media 18.104.22.168.4.1 Specialty Media is Suitable for the Growth of Selective Cell Types 22.214.171.124 Reagents 126.96.36.199.1 Growth Factors 188.8.131.52.1.1 Growth Factors are Unique Cell Signaling Molecules That Help in Cell Proliferation & Development 184.108.40.206.2 Supplements 220.127.116.11.2.1 Supplements Such as Amino Acids Play a Key Role in Inducing Cell Growth 18.104.22.168.3 Buffers & Chemicals 22.214.171.124.3.1 Chemical Buffers are Widely Used, But It Can be Toxic at Higher Concentrations 126.96.36.199.4 Cell Dissociation Reagents 188.8.131.52.4.1 Dissociation Reagents Can be Enzymatic or Non-Enzymatic 184.108.40.206.5 Balanced Salt Solutions 220.127.116.11.5.1 Balanced Salt Solutions Find Wide Applications in Life Sciences 18.104.22.168.6 Attachment & Matrix Factors 22.214.171.124.6.1 The Development of Cells is Dependent on Attachment Factors 126.96.36.199.7 Antibiotics/Antimycotics 188.8.131.52.7.1 The Possibility of Contamination Risks Make the Long-Term Use of Antibiotics/Antimycotics Conditional 184.108.40.206.8 Contamination Detection Kits 220.127.116.11.8.1 Contamination Detection Kits Provide Rapid Results 18.104.22.168.9 Cryoprotective Reagents 22.214.171.124.9.1 Cryoprotective Reagents Protect Tissues/Cells from Damage due to Freezing 126.96.36.199.10 Other Cell Culture Reagents 188.8.131.52 Sera 184.108.40.206.1 Fetal Bovine Sera (FBS) 220.127.116.11.1.1 Use of FBS is Now Restricted due to Regulatory Guidelines 18.104.22.168.2 Adult Bovine Sera (ABS) 22.214.171.124.2.1 ABS is a Cost-Effective Alternative to FBS and is Used as a Biochemical Reagent in IVD 126.96.36.199.3 Other Animal Sera 6.3.2 Vessels 188.8.131.52 Roller/Roux Bottles 184.108.40.206.1 Roller Bottles Offer an Economical Means of Cultivating Large Cell Volumes 220.127.116.11 Cell Factory Systems/Cell Stacks 18.104.22.168.1 Cell Stacks Require Special Handling Equipment and Skilled Expertise 22.214.171.124 Multiwell Plates 126.96.36.199.1 Larger Well Formats Allow for Greater Culture Volumes 188.8.131.52 Flasks 184.108.40.206.1 Disposable Flasks are in Greater Demand Among End-users 220.127.116.11 Petri Dishes 18.104.22.168.1 The Wide Usage of Petri Dishes is Attributed to Ease of Use 6.3.3 Bioreactor Accessories 6.4 Equipment 6.4.1 Supporting Equipment 6.4.2 Bioreactors 6.4.3 Storage Equipment
7 Cell Culture Market, by Application 7.1 Introduction 7.2 Impact of the COVID-19 on the Cell Culture Market 7.3 Biopharmaceutical Production 7.3.1 Therapeutic Proteins 22.214.171.124 Growing Applications of Recombinant Proteins to Drive the Growth of this Segment 126.96.36.199 Rising Incidence of Disease Outbreaks to Drive the Market Growth for Vaccine Production 7.4 Diagnostics 7.4.1 The Growing Risk of Viral Infections Drives the Uptake of Cell Culture Products for Diagnostics 7.5 Drug Screening & Development 7.5.1 Increasing Adoption of Cell-Based Assays in R&D Activities to Drive Segment Growth 7.6 Stem Cell Research 7.6.1 Increasing Stem Cell Research Activities & Investments Drive Segment Growth 7.7 Tissue Engineering and Regenerative Medicine 7.7.1 Increasing Funding for Regenerative Medicine Boosts Segment Growth 7.8 Other Applications
8 Cell Culture Market, by End-user 8.1 Introduction 8.2 Impact of the COVID-19 on the Cell Culture End-User Market 8.3 Pharmaceutical & Biotechnology Companies 8.3.1 Growing Regulatory Approvals for Cell-Culture Based Vaccines Drives Segment Growth 8.4 Hospitals and Diagnostic Laboratories 8.4.1 Increasing Applications of Cell Culture for the Diagnosis of Various Diseases to Drive Segment Growth 8.5 Research & Academic Institutes 8.5.1 Increasing Government Funding for Research Projects and the High Prevalence of Cancer to Drive Growth for this End-User Segment 8.6 Cell Banks 8.6.1 Increasing Awareness of Preserving Stem Cells to Drive Segment Growth
9 Cell Culture Market, by Region 9.1 Introduction 9.2 COVID-19 Impact on the Cell Culture Market 9.3 North America 9.5 Asia-Pacific 9.6 Latin America 9.7 Middle East and Africa